News
People with bipolar disorder are almost 7 times more likely to develop Parkinson's than those without the condition, according to new research published in the journal Neurology.
The STEADY-PD clinical trial has failed to show that isradipine is an effective treatment to slow or stop progression in early Parkinson's.
Research shows that problems with recycling in brain cells in Parkinson's are overcome by the malaria drug clioquinol.
News about joint work with the Scottish Government to research exercise and impact it has on Parkinson's.
Results from a trial of spinal cord stimulation carried out in Ontario, Canada highlights its potential for improving walking in Parkinson's.
Figures released on World Parkinson's Day reveal astonishing levels of harassment and discrimination faced by people with Parkinson's.
Researchers have identified small molecules secreted by the skin that are maybe responsible for a unique scent in people with Parkinson's.
Research shows that deep brain stimulation may help boost energy levels in Parkinson’s brain cells by increasing the size of mitochondria.
The pioneering GDNF clinical trials programme delivered an experimental treatment directly to the brain. The trial results offer hope that it may be possible to restore the cells damaged in Parkinson’s.
Researchers at King’s College London are starting a world-first clinical trial to test if a probiotic drink could help with motor and non-motor symptoms of Parkinson's.